{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:20Z","timestamp":1767134900863,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":78,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004316.pub3","type":"reference-entry","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T19:45:17Z","timestamp":1175629517000},"source":"Crossref","is-referenced-by-count":15,"title":["Steroid hormones for contraception in men"],"prefix":"10.1002","author":[{"given":"David A","family":"Grimes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria F","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth F","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,18]]},"reference":[{"key":"10.1002\/14651858.CD004316.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.1939-4640.1999.tb02535.x","article-title":"A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations","volume":"20","author":"Anawalt","year":"1999","journal-title":"Journal of Andrology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0015-0282(00)01490-4","article-title":"Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression","volume":"74","author":"Anawalt","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004316.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2164\/jandrol.04135","article-title":"Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial","volume":"26","author":"Anawalt","year":"2005","journal-title":"Journal of Andrology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/j.1939-4640.2004.tb03164.x","article-title":"Intratesticuilar testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen","volume":"25","author":"Coviello","year":"2004","journal-title":"Journal of Andrology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1210\/jcem.87.8.8773","article-title":"Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception","volume":"87","author":"Anderson","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/17.11.2869","article-title":"Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone","volume":"17","author":"Anderson","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB7|cit7","first-page":"427","article-title":"Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens","volume":"77","author":"Bagatell","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB8|cit8","first-page":"757","article-title":"Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach","volume":"81","author":"Bebb","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB9|cit9","first-page":"84","article-title":"Depot gondatropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clincal trial of male contraception","volume":"74","author":"Behre","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB10|cit10","first-page":"2394","article-title":"Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders","volume":"80","author":"Behre","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/humrep\/dei300","article-title":"A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive","volume":"21","author":"Brady","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1210\/jcem.87.8.8710","article-title":"Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone","volume":"87","author":"Gonzalo","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/jc.2003-031307","article-title":"Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in Chinese men","volume":"89","author":"Gu","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/j.1939-4640.2004.tb02846.x","article-title":"Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in Chinese men","volume":"25","author":"Gui","year":"2004","journal-title":"Journal of Andrology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB15|cit15","first-page":"4113","article-title":"Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot","volume":"81","author":"Handelsman","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/humrep\/15.3.672","article-title":"Oestradiol enhances testosterone-induced suppression of human spermatogenesis","volume":"15","author":"Handelsman","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.2004-0895","article-title":"A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception","volume":"90","author":"Hay","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/jcem.87.2.8218","article-title":"An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations","volume":"87","author":"Kamischke","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/j.1939-4640.2001.tb02157.x","article-title":"Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride","volume":"22","author":"Kinniburgh","year":"2001","journal-title":"Journal of Andrology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/17.6.1490","article-title":"Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospemia in both Caucasian and Chinese men","volume":"17","author":"Kinniburgh","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/humrep\/15.7.1515","article-title":"Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men","volume":"15","author":"Martin","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/jcem-70-1-282","article-title":"Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production","volume":"70","author":"Matsumoto","year":"1990","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/jc.2004-1228","article-title":"Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist","volume":"90","author":"Matthiesson","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1210\/jc.2005-0639","article-title":"Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men","volume":"90","author":"Matthiesson","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/humrep\/del094","article-title":"Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men","volume":"21","author":"Meriggiola","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/jc.2004-1852","article-title":"Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesisis, reproductive hormones, testis, and prostate","volume":"90","author":"Meriggiola","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD004316.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1210\/jc.2008-0265","article-title":"Male hormonal contraception: a double-blind, placebo-controlled study","volume":"93","author":"Mommers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD004316.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.01024.x","article-title":"Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception","volume":"53","author":"Kamischke","year":"2000","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1002\/14651858.CD004316.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2265.2000.01143.x","article-title":"Erratum","volume":"53","author":"Nieschlag","year":"2000","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2605.2001.00319.x","article-title":"Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception","volume":"24","author":"Pollanen","year":"2001","journal-title":"International Journal of Andrology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2164\/jandrol.106.000281","article-title":"Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men","volume":"27","author":"Qoubaitary","year":"2006","journal-title":"Journal of Andrology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1210\/jc.2002-022043","article-title":"A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men","volume":"88","author":"Eckardstein","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1210\/jc.2006-0222","article-title":"Direct effect of progestogen on gene expression in the testis during gonadoptropin withdrawal and early suppression of spermatogenesis","volume":"91","author":"Walton","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD004316.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2164\/jandrol.107.002683","article-title":"7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men","volume":"28","author":"Walton","year":"2007","journal-title":"J Androl"},{"key":"10.1002\/14651858.CD004316.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jc.2005-1743","article-title":"Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men","volume":"91","author":"Wang","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1210\/jc.2007-0367","article-title":"Transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis","volume":"92","author":"Cui","year":"2007","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD004316.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1210\/jc.2007-0367","article-title":"Transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis","volume":"92","author":"Wang","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD004316.pub3-BIB38|cit38","first-page":"112","article-title":"Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism","volume":"84","author":"Wu","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB39|cit39","first-page":"902","article-title":"Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone","volume":"81","author":"Anderson","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB40|cit40","first-page":"393","article-title":"Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men","volume":"75","author":"Behre","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/humrep\/16.12.2570","article-title":"Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone","volume":"16","author":"Behre","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2265.2003.01751.x","article-title":"Demonstration of progesterone receptor-mediated gonadotrophin suppression in the human male","volume":"58","author":"Brady","year":"2003","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB43|cit43","first-page":"1244","article-title":"Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception","volume":"84","author":"Buchter","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2004-0802","article-title":"Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression","volume":"90","author":"Coviello","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB45|cit45","first-page":"303","article-title":"Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception","volume":"86","author":"Kamischke","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/humrep\/deg140","article-title":"Response of serum inhibin B and pro-alpha C levels to gonadotrophic stimulation in normal men before and after steroidal contraceptive treatment","volume":"18","author":"Matthiesson","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB47|cit47","first-page":"32 pp","article-title":"The relative roles of FSH and LH in maintaining spermatogonial maturation and spermiation in normal men","volume":"advance Aug 8","author":"Matthiesson","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/jcem.87.2.8231","article-title":"Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men","volume":"87","author":"McLachlan","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB49|cit49","first-page":"3018","article-title":"A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive","volume":"81","author":"Meriggiola","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/humrep\/13.5.1225","article-title":"Low dose of cyproterone acetate and testosterone enanthate for contraception in men","volume":"13","author":"Meriggiola","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004316.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1210\/jcem.87.5.8514","article-title":"Twenty-one day administration of dienogest reversibly suppresses gonadotropins and testosterone in normal men","volume":"87","author":"Meriggiola","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1210\/jc.2003-030574","article-title":"Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men","volume":"88","author":"Meriggiola","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2006.11.003","article-title":"Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen","volume":"75","author":"Amory","year":"2007","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004316.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1210\/jc.2006-1411","article-title":"Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist","volume":"91","author":"Page","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2164\/jandrol.107.002790","article-title":"Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment","volume":"28","author":"Page","year":"2007","journal-title":"Journal of Andrology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB56|cit56","unstructured":"ISRCTN80724703 The effect of Testosterone Undecanoate (TU) alone or combined with Depo Medroxyprogesterone Acetate (DMPA) on sperm production of Indonesian fertile men http:\/\/www.controlled-trials.com\/ISRCTN80724703"},{"key":"10.1002\/14651858.CD004316.pub3-BIB57|cit57","unstructured":"NCT00812630 A two-part trial assessing the effects of 7\u03b1-methyl-19-nortestosterone (MENT) on blood pressure in normal men: an open-label pilot study followed by a randomized, double-blind placebo-controlled study http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00812630"},{"key":"10.1002\/14651858.CD004316.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ncpendmet0069","article-title":"Drug insight: recent advances in male hormonal development","volume":"2","author":"Amory","year":"2006","journal-title":"Nature clinical practice. Endocrinology & metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/07853890109002104","article-title":"Advances in male hormonal contraception","volume":"33","author":"Anawalt","year":"2001","journal-title":"Annals of Medicine"},{"key":"10.1002\/14651858.CD004316.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1258\/0007142001903300","article-title":"Hormonal contraception in the male","volume":"56","author":"Anderson","year":"2000","journal-title":"British Medical Bulletin"},{"key":"10.1002\/14651858.CD004316.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(79)90084-2","article-title":"Pregnancies associated with sperm concentrations below 10 million\/ml in clinical studies of a potential male contraceptive method monthly, depot medroxyprogesterone acetate and testosterone esters","volume":"20","author":"Barfield","year":"1979","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004316.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004316.pub3-BIB63|cit63","first-page":"1257","article-title":"Recommendations for nomenclature in andrology","volume":"2","author":"Eliasson","year":"1970","journal-title":"Andrologia"},{"key":"10.1002\/14651858.CD004316.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.fertnstert.2007.04.013","article-title":"\"Oligozoospermia,\" \"azoospermia,\" and other semen-analysis terminology: the need for better science","volume":"88","author":"Grimes","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004316.pub3-BIB65|cit65","first-page":"338","article-title":"Male contraception","volume":"2","author":"Jensen","year":"2002","journal-title":"Current Women's Health Reports"},{"key":"10.1002\/14651858.CD004316.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/01.ogx.0000182905.71077.13","article-title":"Nonhormonal drugs for contraception in men: a systematic review","volume":"60","author":"Lopez","year":"2005","journal-title":"Obstetrical and Gynecological Survey"},{"key":"10.1002\/14651858.CD004316.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004316.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2007-0041","article-title":"Advances in male contraception","volume":"29","author":"Page","year":"2008","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD004316.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm0496-398","article-title":"The myth of a male pill","volume":"2","author":"Potts","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1002\/14651858.CD004316.pub3-BIB70|cit70","volume-title":"Stedman's Medical Dictionary","author":"Stedman","year":"2000"},{"key":"10.1002\/14651858.CD004316.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13625180600699548","article-title":"Male contraception: a realistic option?","volume":"11","author":"Wenk","year":"2006","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD004316.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0140-6736(90)92416-F","article-title":"Contraceptive efficacy of testosterone-induced azoospermia in normal men","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004316.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(16)58221-1","article-title":"Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men","volume":"65","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004316.pub3-BIB74|cit74","volume-title":"WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction","year":"1999"},{"key":"10.1002\/14651858.CD004316.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0015-0282(16)58166-7","article-title":"Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility","volume":"65","author":"Wu","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004316.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2005.12.017","article-title":"Hormonal approaches to male contraception: Approaching reality","volume":"250","author":"Wu","year":"2006","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1002\/14651858.CD004316.pub3-BIB77|cit77","first-page":"3642","article-title":"A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men","volume":"84","author":"Zhang","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004316.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.10.001","article-title":"Steroid hormones for contraception in men: systematic review of randomized controlled trials","volume":"71","author":"Grimes","year":"2005","journal-title":"Contraception"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004316.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T00:00:00Z","timestamp":1331683200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004316.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T13:42:57Z","timestamp":1707745377000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004316.pub3"}},"subtitle":[],"editor":[{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,4,18]]},"references-count":78,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004316.pub3","relation":{},"subject":[],"published":{"date-parts":[[2007,4,18]]}}}